136 related articles for article (PubMed ID: 2142237)
1. Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal women.
Mäenpää J; Söderström KO; Grönroos M; Taina E; Hajba A; Kangas L
J Steroid Biochem; 1990 Jun; 36(3):221-3. PubMed ID: 2142237
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
Ellmén J; Hakulinen P; Partanen A; Hayes DF
Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
[TBL] [Abstract][Full Text] [Related]
3. Hormonal effects of toremifene in breast cancer patients.
Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
[TBL] [Abstract][Full Text] [Related]
4. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU
Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837
[TBL] [Abstract][Full Text] [Related]
5. Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: phase I study.
Kivinen S; Mäenpää J
J Steroid Biochem; 1990 Jun; 36(3):217-20. PubMed ID: 2142236
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic properties of raloxifene.
Draper MW; Flowers DE; Neild JA; Huster WJ; Zerbe RL
Pharmacology; 1995 Apr; 50(4):209-17. PubMed ID: 7792309
[TBL] [Abstract][Full Text] [Related]
7. Influence of antiestrogen drugs on the sex hormone and sex hormone-binding globulin levels in breast cancer patients.
Számel I; Hindy I; Vincze B; Kerpel-Fronius S; Eckhardt S
Ann N Y Acad Sci; 1988; 538():265-79. PubMed ID: 2973277
[No Abstract] [Full Text] [Related]
8. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study.
Valavaara R; Pyrhönen S; Heikkinen M; Rissanen P; Blanco G; Thölix E; Nordman E; Taskinen P; Holsti L; Hajba A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):785-90. PubMed ID: 2968265
[TBL] [Abstract][Full Text] [Related]
9. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy.
Ottosson UB; Carlström K; Johansson BG; von Schoultz B
Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151
[TBL] [Abstract][Full Text] [Related]
10. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
Mäenpää JU; Ala-Fossi SL
Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
[TBL] [Abstract][Full Text] [Related]
11. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
Baker VL; Draper M; Paul S; Allerheiligen S; Glant M; Shifren J; Jaffe RB
J Clin Endocrinol Metab; 1998 Jan; 83(1):6-13. PubMed ID: 9435408
[TBL] [Abstract][Full Text] [Related]
12. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
[TBL] [Abstract][Full Text] [Related]
13. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
14. Effect of toremifene on the activity of NK-cells in NZB/NZW mice.
Wärri A; Kangas L
J Steroid Biochem; 1990 Jun; 36(3):207-9. PubMed ID: 2142234
[TBL] [Abstract][Full Text] [Related]
15. [The anti-estrogenic effect of 4-chloro-1,2-diphenyl-1-(4-[2-(N,N-dimethylamino)ethoxy]phenyl)1-butene (Toremifene) on the endocrine regulation in breast cancer patients].
Számel I; Hindy I; Vincze B; Ady N; Eckhardt S
Orv Hetil; 1991 Mar; 132(13):683-6. PubMed ID: 1826556
[TBL] [Abstract][Full Text] [Related]
16. Review of the pharmacological properties of toremifene.
Kangas L
J Steroid Biochem; 1990 Jun; 36(3):191-5. PubMed ID: 2142231
[TBL] [Abstract][Full Text] [Related]
17. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
[TBL] [Abstract][Full Text] [Related]
18. Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial.
Rutanen EM; Heikkinen J; Halonen K; Komi J; Lammintausta R; Ylikorkala O
Menopause; 2003; 10(5):433-9. PubMed ID: 14501605
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and partial oestrogen agonism in postmenopausal women.
Miodrag A; Ekelund P; Burton R; Castleden CM
Age Ageing; 1991 Jan; 20(1):52-4. PubMed ID: 1903020
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
Robinson SP; Jordan VC
Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
